Frontier Lifeline Hospital Pioneering a Breakthrough in Pulmonary Hypertension Treatment
The team at frontier lifeline hospital successfully performed a landmark procedure, marking one of the very few pulmonary artery denervation cases in India.
A 55-year-old woman presented with severe pulmonary hypertension and right heart failure, showing no significant improvement despite multiple medications aimed at decreasing her pulmonary pressure. Her mean pulmonary artery pressure was critically high at 85mmHg, causing her clinical status to continually decline. After an extensive diagnostic evaluation, she was diagnosed with idiopathic pulmonary hypertension, a condition lacking effective treatment options.
The teams frontier life line hospital opted for pulmonary artery denervation, a novel therapy at the forefront of medical research. This procedure holds promise as an innovative solution for reducing pulmonary pressure. The breakthrough treatment led to a significant reduction in the patient’s pulmonary artery pressure by 15mmHg, signifying hope for significant long-term improvements.
Dr. Sam Jacob, head of electrophysiology program commented that “This procedure represents a potential turning point for patients suffering from pulmonary artery hypertension, a condition where we’ve previously had limited treatment options. We are optimistic about the possibilities this therapy presents in changing lives.”
The pulmonary artery denervation therapy is currently within the clinical trial phase yet presents a beacon of hope for patients with pulmonary arterial hypertension (PAH), as it could revolutionize existing treatment protocols.
Frontier Lifeline Hospital is dedicated to staying at the forefront of medical advancements and providing cutting-edge treatments to cardiac patients. This successful procedure underscores their commitment to patient care and medical innovation, aligning with the mission of Dr KM Cherian Heart Foundation to enhance cardiac treatments and outcomes .
